FDA Hearings on CBD Products Prompt Talk of ‘Wild West’

By: Wendel Rosen | 07/23/2019

Wendel Rosen attorney Bill Acevedo is quoted in the article “FDA hearings on CBD products prompt talk of ‘Wild West’,” which published on May 31, 2019 in S&P Global.

To read more, please click here.

 

 

Related Posts

Title
USDA Rulemaking a Game Changer for the California Hemp Market
California Hemp Ramps Up
CBD is Growing Fast, but Several Hurdles Could Slow Progress
FDA Hearings on CBD Products Prompt Talk of ‘Wild West’
Top Three Takeaways from Toronto’s Big Cannabis Conference
Cannabis Cultivators Get Help with State Regulations
Legalized Cannabis 2019 – What Lies Ahead?
Canada Goes Legal and Gains Competitive Edge
Provisional License Offers Lifeline to California Cannabis Operators
Local Governments Likely to Oppose Expanded Delivery Services